Zonisamide
Links shared publicly online about this topic
Neurology News & Articles - MDLinx - Zonisamide on #MDlinx
mdlinx.com — “Neurology News & Articles - MDLinx - Zonisamide on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 19, 2010 at 6:41 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Zonisamide discontinuation due to psychiatric and cognitive adverse events: Neurology http://bit.ly/b0qP3u #neurology #mdlinx
Seizure Drug Zonisamide Can Cause Metabolic Acidosis
usrecallnews.com — “FDA has warned heathcare professionals about the potential for patients taking the anticonvulsant (anti-seizure) drug Zonisamide to develop Metabolic Acidosis, a blood PH imbalance that can result in hyperventilation, and non-specific symptoms such as fatigue and anorexia, or more severe symptoms including cardiac arrhythmias or stupor, and can have adverse effects on the kidneys and on bones, and can retard growth in children.” View full resource at usrecallnews.com
Most Recently Shared on February 23, 2009 at 11:53 pm By:
New blog post: Seizure Drug Zonisamide Can Cause Metabolic Acidosis http://tinyurl.com/d4w4v8
Zonegran (Zonisamide) Shows Promise In Treatment For Partial Epilepsy In Children
medicalnewstoday.com — “Preliminary results from a new Phase III pediatrics study, announced by Eisai, demonstrate that the anti-epilepsy treatment Zonegran(R) (zonisamide/ZNS) is more effective than placebo and well tol” View full resource at medicalnewstoday.com
Most Recently Shared on September 1, 2011 at 7:01 pm By:
Zonegran (Zonisamide) Shows Promise In Treatment For Partial Epilepsy In Children: Preliminary results from a ne... http://t.co/lsz3oLJ
New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients
medicalnewstoday.com — “Eisai Europe Ltd, a subsidiary of Eisai Co., Ltd (Headquarters: Tokyo; President and CEO: Haruo Naito), today announced the results from a new Phase III study (E2090-E044-310 Monotherapy Study) wh” View full resource at medicalnewstoday.com
Most Recently Shared on July 13, 2011 at 5:50 am By:
New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients: Eisai Eu... http://bit.ly/qoW70N
New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients
medicalnewstoday.com — “Eisai Europe Ltd, a subsidiary of Eisai Co., Ltd (Headquarters: Tokyo; President and CEO: Haruo Naito), today announced the results from a new Phase III study (E2090-E044-310 Monotherapy Study) wh” View full resource at medicalnewstoday.com
Most Recently Shared on July 13, 2011 at 3:21 am By:
Danielle M.Rocheford Patient Expert
New Study Shows Zonegran(R) (Zonisamide) Monotherapy Is Effective In Newly Diagnosed Epilepsy Patients: Eisai Eu... http://bit.ly/oEtp4X
Anticonvulsant Zonisamide (Zonegran) May Treat Alcohol Abuse : Bipolar Network News
bipolarnews.org — “Anticonvulsant Zonisamide (Zonegran) May Treat Alcohol Abuse : Bipolar Network News” View full resource at bipolarnews.org
Most Recently Shared on April 29, 2010 at 8:39 pm By:
Peter H Brown Doctor and Psychologist
Anticonvulsant Zonisamide (Zonegran) May Treat Alcohol Abuse ... http://bit.ly/d00syH
EMA Accepts Eisai's License Extension Application for Zonisamide in Epilepsy | Eisai Europe Limited | Presseportal.de
presseportal.de — “Eisai Europe Limited: Hatfield, England (ots/PRNewswire) - Eisai today announced that the European Medicines Agency (EMA) has accepted for review their application to extend the use of zonisamide as mon” View full resource at presseportal.de
Most Recently Shared on July 28, 2011 at 1:42 pm By:
EMA Accepts Eisai's License Extension Application for Zonisamide in Epilepsy: Hatfield, England (ots/PRNewswire)... http://bit.ly/ql6IXT
EMA Accepts EISAI´S License Extension Application for Zonegran (zonisamide) in Epilepsy (28. Juli 2011, 01:01 Uhr)
wallstreet-online.de — “HATFIELD, England, July 28, 2011 /PRNewswire/ Eisai today announced that the European Medicines Agency (EMA) has accepted for review their application to extend the use of Zonegran (zonisamide) as monotherapy for newly diagnosed epilepsy ...” View full resource at wallstreet-online.de
Most Recently Shared on July 28, 2011 at 1:38 am By:
EMA Accepts EISAI´S License Extension Application for Zonegran (zonisamide) in Epilepsy: HATFIELD, England, July... http://bit.ly/o7sNqB
Eisai Opens for Business in the Netherlands - Drugs.com MedNews
drugs.com — “HATFIELD, England, - Epilepsy Treatment Zonegran(R) First Commercially Available Product Eisai Europe Limited, a subsidiary of Eisai Co., Ltd (Headquarters Toky” View full resource at drugs.com
Most Recently Shared on January 13, 2011 at 4:09 pm By:
Drugs and Devices OW OW Health
Eisai Opens for Business in the Netherlands: HATFIELD, England, January 13, 2011/PRNewswire-FirstCall/ -- ... http://bit.ly/gOkLhw #drug
Psychiatry Article | Alcohols
mdlinx.com — “Zonisamide versus Diazepam in the Treatment of Alcohol Withdrawal Syndrome” View full resource at mdlinx.com
Most Recently Shared on November 7, 2010 at 9:42 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Zonisamide versus Diazepam in the Treatment of Alcohol Withdrawal Syndrome: Pharmacopsychiatry http://bit.ly/ba4zkh #PSY
Family Medicine Article | Alcohols
mdlinx.com — “Zonisamide versus Diazepam in the Treatment of Alcohol Withdrawal Syndrome” View full resource at mdlinx.com
Most Recently Shared on November 5, 2010 at 7:38 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Zonisamide versus Diazepam in the Treatment of Alcohol Withdrawal Syndrome: Pharmacopsychiatry http://bit.ly/al8aUn #FamPractice
Psychiatry Medical News about Schizophrenia
mdlinx.com — “Zonisamide-Induced Weight Loss in Schizophrenia: Case Series” View full resource at mdlinx.com
Most Recently Shared on April 15, 2010 at 5:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Zonisamide-Induced Weight Loss in Schizophrenia: Case Series: Clinical Neuropharmacology http://bit.ly/az9mTY #PSY
Neurology Article | Migraine
mdlinx.com — “Zonisamide Versus Topiramate in Migraine Prophylaxis: A Double-Blind Randomized Clinical Trial” View full resource at mdlinx.com
Most Recently Shared on July 21, 2011 at 8:31 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Zonisamide Versus Topiramate in Migraine Prophylaxis: A Double-Blind Randomized Clinical Trial: Clinical ... http://bit.ly/qvHfCW #neuro
Internal Medicine Article - Unverricht-Lundborg Syndrome
mdlinx.com — “A pilot open-label trial of zonisamide in Unverricht-Lundborg disease” View full resource at mdlinx.com
Most Recently Shared on October 28, 2010 at 3:34 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease: Movement Disorders http://bit.ly/bR59IV #medicine
Neurology Article | Epilepsy
mdlinx.com — “Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy” View full resource at mdlinx.com
Most Recently Shared on May 6, 2011 at 7:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy: Seizure - Europ... http://bit.ly/kRR1rC #neuro
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
usrecallnews
Be the first to know about dangerous product recalls!
-
Epilepsy OW
Organizing epilepsy resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
